ZX Market Snapshot: August 2022:
ZXData Reported Holdings: Three months ending June 30th, 2022
1 Dollar-weighted return on all reported holdings
2 Equal-weighted mark-up or mark-down across all reported holdings
3 Positive Trend Reversal reflects an individual holding marked up after consecutive quarterly periods marked down or flat
4 Negative Trend Reversal reflects an individual holding marked down after consecutive quarterly periods marked up or flat
| Company | Normalized Std Dev5 | $ Weighted Avg | Max | Min |
|---|---|---|---|---|
| Lime | 1.4 | $0.03 | $0.10 | $0.00 |
| D2IQ | .83 | $0.94 | $3.82 | $0.67 |
| Blink Health | .62 | $24.68 | $38.18 | $7.11 |
| Automattic | .44 | $40.33 | $53.96 | $16.75 |
| Carbon 3D | .39 | $12.72 | $24.34 | $5.35 |
5 Normalized Standard Deviation is used to express the measure of spread across reported marks and allows for comparison between companies independent of their price per share based on a dollar-weighted average.
6 Premium and Discount agnostic to share class
SpaceX
Flexport
Stripe
Databricks
Epic Games
Klarna
Kraken
Addepar
ConsenSys
Attentive7 Companies that received the most ticket and profile view activity over the last 30 days
SpaceX, Flexport and Stripe were the three most active companies on ZX in August.
ZX received 80% more asks than bids in August as the order book continues to skew to the sell-side. August transactions priced from a 12.0% premium to a 60.4% discount to June average reported holding values.
On average, ZX Buy Orders sit at a 15% premium to June’s median holding values, highlighted by bids in GupShup and SpaceX. On the sell-side, ZX saw offers sit at a 34.8% average discount to June median holding values, with Ripple, BYJU's and ConsenSys rounding out the top three.
This quarter reporting holders marked down their private portfolios 3.7% with an average mark-down of 10.3%. The period saw five companies decline for each advancing company.
Astera Labs saw the largest mark-up this reporting period, with Affinivax, Circle, and Docker rounding out the largest gainers.Go Maps saw the largest mark-down this reporting period, with JUUL, BlockFi, and Fabletics rounding out the largest decliners. Blockchain & Cryptocurrency saw the largest appreciation across sectors which was largely driven by appreciation in Circle.
Docker and ElevateBio saw their first positive reversals in a year. Nurx saw their first negative reversal in eleven quarters, while Gusto and Yasso saw their first negative reversals in two years.
This period, Lime($0.00 - $0.10) saw the highest share price variance as some funds wrote off their positions.
This report is based on data reported by 250+ funds and $40 billion+ of value. Many holders of private company shares do not report their holding values and are thus not included in this report’s dataset. Further, many venture-backed private companies are not held by any reporting funds and are thus not included in this report. As such, this report should not be construed as providing a complete picture of shareholder sentiment or venture-backed private company performance. This report does not constitute investment advice or a "research report" as defined by FINRA Rules.
Zanbato, Inc. (“Zanbato”) prepares and disseminates market information about venture-backed private company securities, and the current bids and offers for those securities listed on the ATS operated by Zanbato (“ZX”). The information provided in this report has been prepared by sales, trading, or other non-research functions. Pricing indications and macro commentary are provided for factual information purposes only. This report is not intended to assess the individual merits of a particular investment or strategy, does not constitute a recommendation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. This report does not constitute investment advice. Certain information in this report has been obtained from third party sources and, while such information is believed by Zanbato to be reliable, it has not been independently verified by Zanbato and Zanbato shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with any use of, or reliance on, such third party information. Furthermore, the information contained in this report may not be current due to, among other things, changes in the financial markets or economic environment. Zanbato does not, and has no obligation to, update any such information contained in this report. Any prices or quotations contained herein are indicative only, do not represent firm quotes as to either price or size and should not be used for valuation purposes.
Go to zanbato.com